glp-1 drugs and breast cancer use linked to lower incidence GLP-1 Agonists Poised to Impact
Description
This is an important and evolving topic
This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (76)
Both require a prescription
Ushakumari et al
This framework supports structured conversations about which mechanism profile may provide better alignment with individual biomarker patterns and genetic predispositions
That being said only 4.1 % of patients stopped the 4mg dose which is less than the placebo arm
